Eagle Pharmaceuticals, Inc. Accrued Royalties, Current
Eagle Pharmaceuticals, Inc. had Accrued Royalties, Current of $6.45 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedRoyaltiesCurrent · last filed 2023-08-09
- 2023-06-30: Accrued Royalties, Current $6.45M.
- 2023-03-31: Accrued Royalties, Current $6.31M.
- 2022-12-31: Accrued Royalties, Current $7.21M.
- 2022-09-30: Accrued Royalties, Current $9.72M.
| Period end | Accrued Royalties, Current |
|---|---|
| 2023-06-30 | $6.45M 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $6.31M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $7.21M 10-Q/A · filed 2023-08-09 |
| 2022-09-30 | $9.72M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $10.81M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $9.64M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $5.08M 10-K · filed 2023-03-23 |
| 2021-09-30 | $4.88M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.91M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $4.94M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $6.00M 10-K · filed 2022-03-08 |
| 2020-09-30 | $6.91M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $4.75M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $5.46M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $6.00M 10-K · filed 2021-03-05 |
| 2019-09-30 | $3.48M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $7.13M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $7.20M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $7.14M 10-K · filed 2020-03-02 |
| 2018-09-30 | $6.33M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $6.67M 10-Q · filed 2018-08-07 |
| 2017-12-31 | $4.31M 10-K · filed 2019-02-28 |
| 2017-06-30 | $5.13M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $6.99M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $9.07M 10-K · filed 2018-02-26 |
| 2015-09-30 | $1.52M 10-Q · filed 2015-11-12 |